WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage

In 2019, the Executive Guideline Steering Group (GSG) for World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating of the existing WHO recommendations for advance misoprostol distribution to pregnant women for prevention of PPH (Postpartum haemorrhage) in re...

Full description

Bibliographic Details
Corporate Authors: United States Agency for International Development, Special Programme of Research, Development, and Research Training in Human Reproduction (World Health Organization), World Health Organization
Format: eBook
Language:English
Published: Geneva, Switzerland World Health Organization [2020], 2020
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02109nam a2200325 u 4500
001 EB001999937
003 EBX01000000000000001162838
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
020 |a 9789240013902 
020 |a 9789240013919 
245 0 0 |a WHO recommendation on advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage  |h Elektronische Ressource 
246 3 1 |a Advance misoprostol distribution to pregnant women for prevention of postpartum haemorrhage 
260 |a Geneva, Switzerland  |b World Health Organization  |c [2020], 2020 
300 |a 1 PDF file (ix, 42 pages) 
505 0 |a Includes bibliographical references 
653 |a Postpartum Hemorrhage / prevention & control 
653 |a Misoprostol / therapeutic use 
653 |a Pregnancy / drug effects 
710 2 |a United States  |b Agency for International Development 
710 2 |a Special Programme of Research, Development, and Research Training in Human Reproduction (World Health Organization) 
710 2 |a World Health Organization 
740 0 2 |a WHO recommendations for the prevention and treatment of postpartum haemorrhage 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
500 |a Replacement of WHO recommendations for the prevention and treatment of postpartum haemorrhage, [2012] 
856 4 0 |u http://www.ncbi.nlm.nih.gov/books/NBK564874  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 700 
520 |a In 2019, the Executive Guideline Steering Group (GSG) for World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating of the existing WHO recommendations for advance misoprostol distribution to pregnant women for prevention of PPH (Postpartum haemorrhage) in response to the availability of new evidence. The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage